BioNTech
German mRNA oncology company turned pandemic powerhouse — Comirnaty co-developed with Pfizer; BioNTainer modular mRNA manufacturing units deployed in Africa.
- Country
- Germany
- Revenue
- €3.8B
- Employees
- ~5,300 emp
GMP EU
FDA GMP
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Drug & vaccine development | therapeutics-platforms | High | → |
| mRNA platforms & LNP delivery | therapeutics-platforms | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.